Roche Holding Ltd. Share Price Swiss Exchange
Equities
CH0012032048
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- CHF | - |
|
06-28 | Swiss Market Index Closes Little Changed Amid Key European Inflation Data | MT |
06-28 | Roche's Eye Therapy Vabysmo Gets EU Panel's Nod for Additional Indication | MT |
Sales 2024 * | 60.61B 67.43B 5,336B | Sales 2025 * | 64B 71.2B 5,635B | Capitalization | 202B 224B 17,741B |
---|---|---|---|---|---|
Net income 2024 * | 13.25B 14.74B 1,167B | Net income 2025 * | 14.76B 16.42B 1,299B | EV / Sales 2024 * | 3.56 x |
Net Debt 2024 * | 14.09B 15.68B 1,240B | Net Debt 2025 * | 9B 10.02B 793B | EV / Sales 2025 * | 3.29 x |
P/E ratio 2024 * |
14.7
x | P/E ratio 2025 * |
13.3
x | Employees | - |
Yield 2024 * |
3.92% | Yield 2025 * |
4.03% | Free-Float | 88.91% |
Latest transcript on Roche Holding Ltd.
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 49 | 31/12/02 | |
Severin Schwan
CHM | Chairman | 57 | 31/12/07 |
Alan Hippe
DFI | Director of Finance/CFO | 57 | 31/03/11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bernard Poussot
BRD | Director/Board Member | 72 | 02/03/15 |
Director/Board Member | 59 | - | |
Director/Board Member | 66 | 31/12/95 |
1st Jan change | Capi. | |
---|---|---|
+55.32% | 815B | |
+44.05% | 641B | |
-6.75% | 352B | |
+13.56% | 314B | |
+10.68% | 303B | |
+16.57% | 242B | |
+13.31% | 218B | |
+8.48% | 168B | |
-2.81% | 159B |